# Orna Therapeutics

**Canonical:** https://apis.io/providers/orna-therapeutics/  
**Website:** https://www.ornatx.com/  
**APIs profiled:** 0

Orna Therapeutics is a Cambridge, Massachusetts biotechnology company, founded in 2019 on research from MIT and built by MPM Capital, that engineers circular RNA (oRNA) paired with lipid nanoparticle delivery so a patient's own body generates cell therapies — its lead program ORN-252 is a CD19-targeting in vivo CAR-T designed for B-cell-driven autoimmune disease. Orna acquired ReNAgade Therapeutics in 2024, combining its circular RNA platform with ReNAgade's LNP delivery and RNA editing capabilities, and Eli Lilly announced a definitive agreement to acquire Orna on 2026-02-09 for up to $2.4B. Orna is a therapeutics developer, not a software vendor: it publishes no API, developer portal, SDK or machine-readable contract, and as of this profile its own domain ornatx.com redirects in whole to Eli Lilly's subsidiaries page.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 46.3 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Orna Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Therapeutics, RNA, Life Sciences, Pharmaceuticals, Cell Therapy, Research

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/orna-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.